COMMUNIQUÉS West-GlobeNewswire

Kalytera Announces Initiation of Phase 2 Clinical Study in Prevention of Graft Versus Host Disease and Agreement with The Salzman Group of Israel to Manage and Partially Fund the Study to be Led by a World Class Team

07/12/2017 - 14:30

SAN FRANCISCO and TEL AVIV, Israel, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX-V: KALY ) and (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced the initiation of a Phase 2 clinical [...]

Gala Global Inc. Announces Name Change and Shift in Business Strategy

07/12/2017 - 14:15

IRVINE, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Gala Global, Inc. (OTCBB: GLAG ) announces its filing a name change to Gala Pharmaceuticals Inc. The name change more closely aligns Gala Pharmaceuticals Inc., (GPI) to [...]

Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in Cash

07/12/2017 - 14:15

PLYMOUTH, Minn., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ: ENTL ) announced today a definitive merger agreement by which Stryker Corporation (NYSE: SYK ) will acquire Entellus in an all cash [...]

Vericel Enters into Expanded $25 Million Debt Facilities with Silicon Valley Bank and MidCap Financial to Support Accelerating MACI Uptake and Increased Epicel Usage

07/12/2017 - 14:00

CAMBRIDGE, Mass., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, [...]

Tauriga Sciences, Inc. Confirms Multiple Initial Customer Orders for its Licensed Cupuacu Butter Lip Balm Product

07/12/2017 - 14:00

NEW YORK, NY, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) (“Tauriga” or the “Company”), engaged in building business through the development, distribution, and licensing of proprietary [...]

iCAD Announces Study Demonstrating Economic and Health Benefits of Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer Treatment

07/12/2017 - 14:00

Lifetime cost-effectiveness analysis reveals $630 million annual cost savings, less radiation exposure and better quality of life for patients compared to external beam radiation therapy NASHUA, N.H., Dec. 07, 2017 ( [...]

aTyr Pharma to Participate at the BMO Prescriptions for Success Healthcare Conference

07/12/2017 - 14:00

SAN DIEGO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of immuno-modulatory protein therapeutics to treat patients suffering [...]

Iovance Biotherapeutics to Webcast Analyst Day on Wednesday, December 13, 2017

07/12/2017 - 14:00

SAN CARLOS, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]

BeyondSpring to Webcast Key Opinion Leader Event in NYC on Dec. 14, 2017

07/12/2017 - 14:00

NEW YORK, Dec. 07, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ) (“BeyondSpring” or the “Company”), a late-stage clinical biopharmaceutical company focusing on the development of a pipeline of innovative [...]

Jounce Therapeutics to Present at BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference

07/12/2017 - 14:00

CAMBRIDGE, Mass., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]

India Globalization Capital Launches New Corporate Websites Highlighting Canna-Pharmaceutical Compound Portfolio

07/12/2017 - 14:00

BETHESDA, Md., Dec. 07, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), today announced that it has launched two new websites to detail the Company’s cannabinoid pipeline for the [...]

Intra-Cellular Therapies Presents Data on Lumateperone, ITI-214 and ITI-333 at the 56th Annual Meeting of the American College of Neuropsychopharmacology

07/12/2017 - 14:00

NEW YORK, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

07/12/2017 - 13:51

Copenhagen, 2017-12-07 13:51 CET (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) reports the following transactions: 1. Details of the person discharging managerial responsibility / person closely [...]

Beleave Signs Brand Licensing Agreement with Kevin Smith & Jason Mewes

07/12/2017 - 13:45

TORONTO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. (" Beleave " or the " Company ") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has entered into a Brand Licensing Agreement with Kevin Smith and Jason [...]

INC Research/inVentiv Health Strengthens Leadership of Commercial Solutions

07/12/2017 - 13:12

RALEIGH, N.C., Dec. 07, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (NASDAQ: INCR ), the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO (Contract Commercial [...]

Immunovaccine and UConn Health Extend Collaboration to Support Advancement of Patient-Specific Immunotherapies to the Clinic

07/12/2017 - 13:05

HALIFAX, Nova Scotia, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (“Immunovaccine” or the “Company”) (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immunotherapy and vaccine company, today announced an expansion [...]

ObsEva SA to Participate in BMO Healthcare Conference December 14th 2017

07/12/2017 - 13:01

Geneva, Switzerland and Boston, MA -December 7, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]

Fibrocell Announces Pricing of $10.5 Million Underwritten Public Offering

07/12/2017 - 13:00

EXTON, Pa., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]

Advanced Accelerator Applications Announces Commencement of Novartis Tender Offer

07/12/2017 - 13:00

SAINT-GENIS-POUILLY, France, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ: AAAP ) (AAA or the Company), a leader in nuclear medicine theragnostics, today announced that a direct and [...]